SCHEMBL13507964

SCHEMBL13507964

Cc1cccc(N(c2ccccc2)c2ccc3c4c5ccccc5c5c6ccc(N(c7ccccc7)c7cccc(C)c7)cc6n(C)c5c4n(C)c3c2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ POLB P06746 1/20 0.35
▸ ALKBH5 Q6P6C2 1/20 0.35
▸ FTO Q9C0B1 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ USP2 O75604 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ ALOX15 P16050 2/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ TOP2A P11388 1/20 0.33
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB1 P18505 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13507564 0.92 MAPT (0.37) MAPTKDM4EPOLBALKBH5FTO
SCHEMBL13507560 0.92 TP53 (0.39) MAPTKDM4EPOLBALKBH5FTO
SCHEMBL13507879 0.92 KDM4E (0.39) MAPTKDM4EALKBH5FTOALDH1A1
SCHEMBL13508148 0.89 KDM4E (0.41) MAPTKDM4EPOLBALKBH5FTO
SCHEMBL13507961 0.88 KDM4E (0.40) MAPTKDM4EALKBH5FTOALDH1A1
SCHEMBL13508156 0.86 LIMK1 (0.43) MAPTKDM4EPOLBHPGDRXFP1
SCHEMBL18564752 0.86 KDM4E (0.37) MAPTKDM4EALKBH5FTOALDH1A1
SCHEMBL16153219 0.85 KDM4E (0.36) MAPTKDM4EALKBH5FTOALDH1A1
SCHEMBL13507767 0.84 KDM4E (0.37) MAPTKDM4EALDH1A1TP53TOP2A
SCHEMBL13508019 0.83 KIF11 (0.37) MAPTKDM4EALDH1A1TP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 MAPT 2046/4885KDM4E 3009/4885POLB 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback